ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
Innovative Drugs
Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:Financial Reports
ag真人平台官方:Announcements
2014.12.03
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS IV, L.P.进行投资的进展公告
第一页
上一页
103
104
105
106
107
下一页
最后一页
About Hepalink
Group Profile
ag真人平台官方:Corporate Philosophy
Milestones
ag真人平台官方:Leadership Team
Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
